National Academy of Medicine Elects 100 New Members: Part 3

During its annual meeting National Academy of Medicine announced the election of 90 regular members and 10 international members.

Election to the Academy is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.

The National Academy of Medicine (NAM), originally founded as the Institute of Medicine (IOM) in 1970, is one of the three academies that comprise the National Academies of Sciences, Engineering, and Medicine in the United States. With over 2,400 members elected by their peers for their outstanding achievements, NAM plays a crucial role in guiding efforts to improve health and healthcare.

Operating under the 1863 Congressional charter of the National Academy of Sciences, NAM is a private, nonprofit institution that provides objective advice on matters related to science, technology, and health. Its members are dedicated to volunteer service, contributing their expertise to advance the mission of NAM and the broader National Academies.

REGULAR MEMBERS

Beatriz Luna

Beatriz Luna, PhD, Staunton Distinguished Professor of Psychiatry and Pediatrics and professor of psychology, bioengineering, and radiology, University of Pittsburgh School of Medicine, Pittsburgh. For establishing a model of normative adolescent neurocognitive development, identifying neural mechanisms of plasticity supporting the specialization into adulthood of cognitive and motivational systems; informing AMA briefs for the U.S. Supreme Court decisions on juvenile sentencing; and the creation and leadership of the Flux Society for Developmental Cognitive Neuroscience.

Trudy F.C. Mackay

Trudy F.C. Mackay, PhD, FRS, director, Center for Human Genetics, Self Family Endowed Chair of Human Genetics, and professor of genetics and biochemistry, Clemson University, Greenwood, S.C. For being recognized as one of the world’s leading geneticists for pioneering studies on the genetic architecture of complex traits and the discovery of fundamental principles of quantitative genetics with broad applications for medicine.

Nicole Maestas

Nicole Maestas, MPP, PhD, John D. MacArthur Professor of Health Care Policy, Harvard Medical School, Boston. For contributions to our understanding of the economics of employment, work capacity, and income support for people who are disabled or elderly; for national leadership in building the evidence base for disability policymaking; and for contributions to the economics of health insurance for the elderly and people with disabilities.

David J. Mangelsdorf

David J. Mangelsdorf, PhD, professor and chair, department of pharmacology, and investigator, Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas. For landmark discoveries of oxysterol (LXRs) and bile acid (FXR) nuclear receptors that revealed the sensing mechanisms that govern reverse cholesterol transport and bile acid synthesis. He co-discovered the key roles of the endocrine hormones FGF21 and FGF15/19 in regulating lipid and energy metabolism, and bile acid homeostasis, respectively.

Jeanne Marrazzo

Jeanne Marrazzo, MD, MPH, director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md. For leading transformative research that has redefined our understanding of relationships between the vaginal microbiome and female reproductive tract infections, HIV pre-exposure prophylaxis (PrEP), hormonal contraception, and risk of STI/HIV acquisition. She has had key roles in NIH-funded networks — Infectious Diseases Clinical Research Consortium and HIV Prevention Trials.

Erica Elizabeth Marsh

Erica Elizabeth Marsh, MD, MSCI, S. Jan Behrman Collegiate Professor of Reproductive Medicine, vice chair and division chief, reproductive endocrinology and infertility, department of obstetrics and gynecology, University of Michigan Medical School, Ann Arbor. For research on uterine leiomyomas and for her efforts to eliminate disparities in reproductive health. Her commitment to building research capacity in women’s health, both nationally and globally, and her cultivation of the next generation of leaders in reproductive health will have a lasting impact.

Dayna Bowen Matthew

Dayna Bowen Matthew, JD, PhD, dean and Harold H. Greene Professor of Law, George Washington University Law School, Washington, D.C. For advancing our understanding of how policies and legal systems have produced health inequities. Her work has resulted in actionable federal policy changes in the United States.

Margaret M. McCarthy

Margaret M. McCarthy, PhD, director, University of Maryland – Medicine Institute for Neuroscience Discovery; and James and Carolyn Frenkil Dean’s Endowed Professor and distinguished university professor, department of pharmacology, physiology, and drug development, University of Maryland School of Medicine, Baltimore. For being the first to discover a critical role of the immune system in determining sex differences and the impact of infection and inflammation on neuroanatomical and behavioral outcomes, which provided mechanistic insights into the higher prevalence of autism spectrum disorders and schizophrenia in boys and men.

Genevieve B. Melton-Meaux

Genevieve B. Melton-Meaux, MD, PhD, senior associate dean, health informatics and data science; director, Center for Learning Health System Sciences; and professor of surgery and health informatics, University of Minnesota, Minneapolis. For research in integrating AI with health care, bridging surgery and informatics, and fueling learning health systems. Melton-Meaux explores complex health dynamics, from optimizing clinical note usage in electronic health records to large-scale detection of social/behavioral health determinants with clinical data. Her work has significantly advanced biomedical informatics, clinical practice, and policy.

Dan Merenstein

Dan Merenstein, MD, professor and director of research programs of family medicine, Georgetown University School of Medicine, and department of human science, Georgetown University School of Health, Washington, D.C. For being an accomplished large-scale clinical trialist in family medicine. His work is inspired by practice and teaching, engaging hundreds of busy primary care practices in real-world research, answering foundational questions that inform daily practice.

Funda Meric-Bernstam

Funda Meric-Bernstam, MD, professor and chair, department of investigational cancer therapeutics, University of Texas MD Anderson Cancer Center, Houston. For leading practice-changing clinical oncology trials in human epidermal growth factor receptor 2 (HER2)-targeted therapy, bringing novel biomarker-driven combination therapies from bench to bedside. She is leading large-scale national efforts in precision oncology such as NCI ComboMATCH and investigator-initiated antibody drug conjugate-MATCH; and leads one of the most influential developmental therapeutics programs in the world.

Matthew J. Miller

Matthew J. Miller, MD, MPH, ScD, professor, department of public health and health sciences, Northeastern University, Boston. For being a nationally recognized researcher who has led foundational epidemiological research on firearm access and suicide, enhanced our understanding of the theoretical underpinnings of suicide prevention via lethal means restriction, and developed clinical interventions illuminating how counseling patients and their families for reducing access to firearms can save lives.

Julie Morita

Julie Morita, MD, president and chief executive officer, The Joyce Foundation, Chicago. For being one of the nation’s most respected public health leaders, who has dedicated her career to advancing health equity. During 20 years in Chicago, she addressed racial and ethnic health disparities, leading implementation of the city’s first health equity plan. Previously, as the Robert Wood Johnson Foundation’s executive vice president, she led strategic planning efforts to ensure all programming focuses on addressing health and racial equity.

Sally C. Morton

Sally C. Morton, PhD, executive vice president, Knowledge Enterprise; and professor of statistics, College of Health Solutions and School of Mathematical and Statistical Sciences, Arizona State University, Tempe. For preeminent leadership in statistics, health policy, and science in both academic and nonprofit research institutions; excellence in evidence synthesis of clinical and public health issues; and impactful methodology in patient-centered comparative effectiveness research. Her pioneering contributions to clinical practice guidelines and health care interventions have reduced morbidity and mortality.

Niki Maria Moutsopoulos

Niki Maria Moutsopoulos, DDS, PhD, senior investigator, Intramural Research Program, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Md. For making seminal contributions toward understanding and treating the prevalent human oral disease periodontitis. Her laboratory has contributed to the understanding of both homeostatic and pathogenic inflammation in the oral cavity, informing interventions for both rare and common forms of aggressive forms of periodontal disease.

Avindra Nath

Avindra Nath, MD, chief, Section of Infections of the Nervous System, and clinical director, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Md. For pioneering research and strong leadership in emerging and persistent infections of the nervous system by studying pathophysiology, developing treatments, and conducting clinical studies. This includes retroviruses, Ebola, Zika, nodding syndrome, and COVID-19 as well as Long COVID, ME/CFS, and Gulf War syndrome.

Jennifer B. Nuzzo

Jennifer B. Nuzzo, DrPH, SM, director, Pandemic Center, Brown University School of Public Health, Providence, R.I. For co-creating the Global Health Security Index and conducting research to measure and improve national preparedness for infectious disease threats. She co-established a global COVID-19 testing data tracker and created a health systems resilience checklist for biological emergencies.

Santa Jeremy Ono

Santa Jeremy Ono, PhD, president, University of Michigan, Ann Arbor. For his work as a molecular immunologist who has studied the regulation of the immune response and the pathogenesis of age-related macular degeneration. He is a recognized leader in higher education who has served as the president of the University of Cincinnati, the University of British Columbia, and now as the 15th president of the University of Michigan.

David Pellman

David Pellman, MD, Howard Hughes Medical Institute investigator and professor of cell biology and pediatrics, Dana-Farber Cancer Institute and Harvard Medical School, Boston. For identifying the mechanistic basis for mutational processes that generate a large fraction of the structural and numerical chromosome abnormalities in cancer and certain congenital diseases. In particular, his discovery of a mechanism explaining chromothripsis is considered a landmark in cancer genetics.

Priscilla Eyikojoka Pemu

Priscilla Eyikojoka Pemu, MD, MS, FACP, FAHA, professor of medicine, department of medicine, Morehouse School of Medicine, Atlanta. For pioneering work on clinical trial diversity, centering on the importance of regaining trust, fostering transparent collaboration, and ensuring the equitable participation of diverse populations in medical research, from Grady health system, a large public hospital, to primary care practices, historically black churches and institutions.

Mary L. Phillips

Mary L. Phillips, MD (Cantab), Pittsburgh Foundation-Emmerling Endowed Chair in Psychotic Disorders and professor in psychiatry, department of psychiatry, University of Pittsburgh, Pittsburgh. For use of state-of-the-art neuroimaging and translational approaches to study neurobiological processes predisposing to bipolar disorder and depression. She has identified biomarkers reflecting these processes to help improve early diagnosis and risk identification in youth, and guide novel neuromodulation treatment developments to improve mental health and functional outcomes for these disorders.

Olivier Pourquié

Olivier Pourquié, PhD, Frank Burr Mallory Professor, department of pathology, Brigham and Women’s Hospital, and department of genetics, Harvard Medical School, Boston. For his discovery of the segmentation clock and landmark work on vertebral development that provides a framework to understand pathologies of the spine such as scoliosis or spina bifida. He is recognized worldwide as a leader in developmental biology and in the use of human stem cells for disease modeling and regeneration of the musculoskeletal system.

Mark R. Prausnitz

Mark R. Prausnitz, PhD, Regents’ Professor, School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta. For innovating on research advancing microneedles and other drug delivery technologies, inventing novel pharmaceutical methods and devices, translating drug delivery technology into clinical trials and medical products, bringing medical advances to patients by founding companies, inspiring students to be creative and impactful engineers, and providing leadership among his colleagues.

INTERNATIONAL MEMBERS

Friday Ebhodaghe Okonofua

Friday Ebhodaghe Okonofua, MD, BSc, MB ChB, PhD, FRCOG, FMCOG, FWACS, FICS, center leader, African Center of Excellence in Reproductive Health Innovation, University of Benin, Benin City, Nigeria. For expertise in reproductive health and leading large national and international research in interventional and implementation research for preventing maternal mortality with impact on policies and programming in African countries. He is committed to gender quality, ethics, and equity in global and Africa settings.

Aziz Sheikh

Aziz Sheikh, OBE, FRSE, FMedSci, Nuffield Professor of Primary Care Health Sciences and head, Nuffield Department of Primary Care Health Sciences, University of Oxford; and professor and director, Usher Institute, University of Edinburgh, Edinburgh, United Kingdom. For being a global leader in health informatics and data science to advance the quality, safety, and efficiency of clinical care internationally. He is a world leader in asthma care and in primary care and has helped lead the COVID response in Scotland.

100 New Members of NAM: Part 1

100 New Members of NAM: Part 2